- ￥1290 - 4190
- Solarbio
- 北京
- IN3170
- 2025年07月23日
企业认证
相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 技术资料
- 保存条件：
Powder:2-8℃，2 years;Insolvent(母液):-20℃，6 months;-80℃，1 year
- 保质期：
Powder:2-8℃，2 years;Insolvent(母液):-20℃，6 months;-80℃，1 year
- 英文名：
NSC 305787
- 库存：
现询
- 供应商：
北京索莱宝科技有限公司
- CAS号：
785718-37-8
- 规格：
1mg/2mg/5mg/10mg
| 规格： | 1mg | 产品价格： | ￥1290.0 |
|---|---|---|---|
| 规格： | 2mg | 产品价格： | ￥2064.0 |
| 规格： | 5mg | 产品价格： | ￥2890.0 |
| 规格： | 10mg | 产品价格： | ￥4190.0 |
| 基本信息 | |
| CAS | No.785718-37-8 |
| 英文名称 | NSC 305787 |
| 分子式 | C25H30Cl2N2O |
| 分子量 | 445.42 |
| 溶解性 | Soluble in DMSO(Need ultrasonic or Water bath) |
| 纯度 | ≥98% |
| 外观(性状) | Solid |
| 储存条件 | Powder:2-8℃，2 years;Insolvent(母液):-20℃，6 months;-80℃，1 year |
| SMILES | C1CCNC(C1)C(C2=CC(=NC3=C2C=C(C=C3Cl)Cl)C45CC6CC(C4)CC(C6)C5)O |
| InChIKey | YNGQUUFYBFKLNH-UHFFFAOYSA-N |
| InChI | InChI=1S/C25H30Cl2N2O/c26-17-8-18-19(24(30)21-3-1-2-4-28-21)10-22(29-23(18)20(27)9-17)25-11-14-5-15(12-25)7-16(6-14)13-25/h8-10，14-16，21，24，28，30H，1-7，11-13H2 |
| PubChem CID | 470998 |
| 靶点 | Ezrin |
| 通路 | Others |
| 背景说明 | NSC305787 是一种 ezrin 抑制剂，抑制 PKCΙ 导致的 ezrin 磷酸化，具有抗肿瘤活性。 |
| 生物活性 | NSC305787 is an inhibitor of ezrin with a Kd of 5.85 μM， inhibits the phosphorylation of ezrin caused by PKCΙ with an IC50 of 8.3 μM， has antitumor activity.[1-2] |
| IC50 | Kd: 5.85 μM (ezrin)[1].IC50: 8.3 μM (ezrin)[1] |
| In Vitro | NSC305787 is an inhibitor of ezrin with a Kd of 5.85 μM， and has antitumor activity. NSC305787 inhibits PKCΙ phosphorylation of Ezrin， Moesin， Radixin， MBP， with IC50s of 8.3， 9.4， 55， 58.9 μM， respectively. NSC305787 binds to PKCΙ with a Kd value of 172.4 μM， and inhibits ezrin T567 phosphorylation primarily via its binding to ezrin and not through inhibition of PKCΙ kinase activity. NSC305787 (1， 10 μM) shows inhibitory activity against ezrin-mediated invasion of K7M2 osteosarcoma (OS) cells. Moreover， NSC305787 (10 μM) reduces cell motility phenotypes in zebrafish and blocks OS metastatic growth in lung organ culture[1]. |
| 细胞实验 | NSC305787 (0.240 mg/kg/day， i.p.) suppresses ezrin-dependent osteosarcoma metastatic growth in mouse lung[1]. NSC305787 (240 μg/kg， i.p.) dramatically inhibits pulmonary metastasis in a transgenic mouse model of osteosarcoma (Osx-Cre+p53fl/flpRBfl/fl) and shows a more favorable pharmacokinetic profile compared with NSC668394 in the mouse model[2]. |
| 细胞实验 | Human umbilical vein endothelial cells (HUVECs; 2.5 × 104/well) are seeded in a 96-well plate in endothelial growth media-2. Following formation of a confluent HUVEC monolayer (～32 h)， endothelial growth media-2 is aspirated and a layer of osteosarcoma (OS) cells (1.0 × 104 cells/well) is added to Dulbecco’s modified Eagle medium containing NSC305787. This specific time point is accepted as 0 h of treatment， and invasion is monitored during the subsequent 5 h by measuring changes in resistance at the cell-electrode interphase. The cell index is calculated according to the following formula: cell index = (Rt – R0)/F， where Rt is resistance at time point t， R0 is background resistance (measured with media alone， no cells) and F is frequency at which the measurement is taken (10 kHz)[1]. |
| 动物实验 | Mice[2]The Osx-Cre+p53fl/flpRBfl/fl transgenic mouse model of osteosarcoma is used in the assay. Mice are treated with 240 μg/kg/day NSC305787， 226 μg/kg/day NSC668394， or vehicle (DMSO， 1%) once daily， five times a week by i.p. injection in a volume of 100 μL. At the end of the study， lung and tumor samples are isolated upon necropsy. Half of each sample is flash frozen immediately in liquid nitrogen， and the other half is fixed in 10% formalin for 18-24 h， transferred to 70% ethanol， and stored at room temperature[2]. |
| 数据来源文献 | [1]. Bulut G， et al. Small molecule inhibitors of ezrin inhibit the invasive phenotype of osteosarcoma cells. Oncogene. 2012 Jan 19;31(3):269-81. [2]. elik H， et al. Ezrin Inhibition Up-regulates Stress Response Gene Expression. J Biol Chem. 2016 Jun 17;291(25):13257-70. |
| 单位 | 瓶 |
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
技术资料暂无技术资料 索取技术资料
IN3170 NSC 305787 抑制剂/拮抗剂/激动剂 索莱宝
￥1290 - 4190
